India cell counting market was valued at $56.8 million in 2025 and is projected to reach $116.6 million by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The growing number of laboratories is emerging as a key trend supporting expansion of the global cell counting market. Increased establishment of research, clinical, and diagnostic laboratories is strengthening demand for accurate and efficient cell counting solutions. This growth is accelerating adoption of automated and high-throughput cell analysis systems across multiple application areas. Countries across regions are witnessing significant expansion in diagnostic and research laboratory infrastructure. Nation such as India is witnessing increased investment in laboratory infrastructure, strengthening capabilities across research, clinical, and diagnostic segments.
Browse the full report description of “Indian Cell Counting Market Size, Share & Trends Analysis Report by Product Type (Instruments and Consumables), By Application (Medical Applications, Research, and Industrial), By End-User (Pharmaceuticals & Biotechnology Companies, Research Institutes & CRO, and Hospitals & Diagnostic Laboratories), Forecast Period 2026-2035” at https://www.omrglobal.com/industry-reports/india-cell-counting-market
Under the national scheme for managing epidemics and calamities, 165 biosafety laboratories have been approved, comprising 11 BSL-3 and 154 BSL-2 facilities. These laboratories are designed to support advanced biological testing and disease surveillance. Additionally, 42 Virus Research and Diagnostic Laboratories have been approved since 2021. Among them, 38 laboratories are already operational, while four received approval during FY2024–25. The steady expansion of such facilities is driving higher volumes of routine and specialized testing. This infrastructure development is reinforcing demand for accurate and efficient cell counting technologies across laboratory environments.
India’s diagnostics sector is expanding capacity and geographic reach as demand rises for preventive, advanced and precision testing. Regional market players such as Dr. Lal PathLabs currently operates about 300 laboratories and over 6,500 sample collection centres nationwide, following a scale-focused, financial-year-based expansion strategy. In FY25, it added 18 laboratories and nearly 900 collection centres, with plans to add 15–20 laboratories and 700–800 centres next year, targeting underserved regions and deeper penetration in existing markets. The company is also launching a preventive wellness centre offering doctor-curated programs.
Major Investments and Capacity Expansion Trends in Cell Counting
The major companies operating in the global cell counting market include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc., among others. Major players in the global cell counting market are focusing on advancing automation, analytical accuracy, and scalability to support growing demand from biopharmaceutical manufacturing and cell and gene therapy research.
Market Coverage
Key questions addressed by the report.
India Cell Counting Market Report Segment
By Product Type
By Application
By End-User
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/india-cell-counting-market